
Deborah Toppmeyer, MD
Advertisement
Articles by Deborah Toppmeyer, MD


ACR Appropriateness Criteria® Ductal Carcinoma in Situ
BySeth A. Kaufman, MD,Eleanor E. R. Harris, MD,Lisa Bailey, MD,Manjeet Chadha, MD,Sharon C. Dutton, MD,Gary M. Freedman, MD,Sharad Goyal, MD,Michele Y. Halyard, MD,Kathleen C. Horst, MD,Kristina L. M. Novick, MD,Catherine C. Park, MD,W. Warren Suh, MD,Deborah Toppmeyer, MD,Jennifer Zook, MD,Bruce G. Haffty, MD
Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.
Advertisement
Latest Updated Articles
ACR Appropriateness Criteria® Ductal Carcinoma in SituJune 15th 2015
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer
2
Teclistamab/Talquetamab Hits Record Low Hazard Ratio in Multiple Myeloma
3
TIL Cell Therapy in HIV Positive Patient With Metastatic Melanoma: Case Report
4
Gedatolisib/Fulvestrant Earns NCCN Category 1 Listing for HR+/HER2- Breast Cancer
5